9841 Washingtonian Blvd, Suite 390 Gaithersburg MD 20878
Web Site: http://www.mphasetech.com
- CEO Anshu Bhatnagar - CFO Chris Cutchens - President Ram Mantravadi -
mPhase Technologies, Inc., is an innovative development company specializing in the fabrication of Smart Surfaces and devices enabled by recent breakthroughs in microfluidics, micro electromechanical systems (MEMS) and nanotechnology. The Company is publicly traded under the stock symbol OTC Pink: XDSL, and has offices in Staten Island, NY and Gaithersburg, MD.
mPhase has a patent portfolio consisting of 10 patents (licensed, solely and jointly owned) issued in the United States, covering Smart Surfaces, an innovative platform technology to control the flow of fluids by electronically (and other means) manipulating the way liquids behave when in contact with a solid or porous surface.
To date, mPhase has concentrated its Smart Surface platform technology on developing a Smart NanoBattery (first battery on a chip), which has a unique architecture that enables:
a shelf life of decades
adaptability to multiple configurations:
- lithium and other chemistries
- primary, secondary (rechargeable), or reserve
environmentally friendly “green” designation
The mPhase platform technology provides upside potential for extended life alternatives to many systems including back-up batteries, oxygen generators and hot/cold packs for use in emergency or survival applications.
Change in Strategic Direction has been announced. Mr. Bhatnagar is currently the CEO of Verus International (VRUS), a global consumer products company, and will continue in that role while also heading the company-building stage at mPhase.
In January of 2019, Anshu Bhatnagar acquired over 20% of the outstanding shares to gain control of this company. He is now President, CEO, and Chairman of the Board of mPhase. Bhatnagar has been in charge of the company since 1/22/2019. Since then he has:
2/4/2019 mPhase Technologies, Inc. Forms New Software and Technology Development Division
2/6/2019 mPhase Technologies, Inc. Announces Strategic Discussions With Global Pharmaceutical Company
To be updated...
Effective May 22, 2019 the Company completed a 5,000/1 reverse split of its Common stock reducing its authorized shares to 25 million shares of Common Stock.